Abstract
Serum CD4, CD8, and CD19 are markers of systemic inflammation. However, there is little evidence on the influence of inflammation on the tumor microenvironment and the prognostic indicators of gastric cancer (GC). In this study, two hundred and eight patients who underwent radical gastrectomy for GC were included. Preoperative peripheral blood samples were used to analyze Serum CD4, CD8, and CD19. The optimal cutoff levels for CD4, CD8, and CD19 were defined by receiver operating characteristic curve analysis (CD4 = 38.85%, CD8 = 14.35%, and CD19 = 7.40%). The areas with specific CD4+T cells, CD8+T cells, and CD19+B cells within the tumor microenvironment were measured in paraffin sections by immunohistochemistry and analyzed by Image-Pro Plus. 94 patients had low CD4, and 124 patients had high CD4 levels. 31 patients had low CD8, and 187 patients had high CD8 levels. 64 patients had low CD19, and 154 patients had high CD19 levels. Infiltration of CD4+T cells was associated with serum CD4 (P < 0.001). Serum CD4 and CD19 and the infiltration of CD4+T cells, CD8+T cells, and CD19+B cells were significant in predicting the prognosis of GC. Low CD4 level, infiltration of CD8+T cells, and high infiltration of CD4+T cells and CD19+B cells were correlated with worse overall survival in multivariate analysis. Collectively, our results provide evidence that serum CD4 is associated with the infiltration of CD4+T cells in the tumor microenvironment, which indicates the prognostic value of systemic inflammation in GC.
Highlights
According to the latest global cancer report, more than 70%of new cases of gastric cancer (GC) and deaths are from developing countries, causing a social burden that cannot be ignored [1, 2]
In 2017, Choi et al [20] first reported that the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) were associated with the density of immune cells in the tumor microenvironment, which leads to prognostic values of systemic inflammation in gastric cancer
We investigated the prognostic value of CD4+T cells, CD8+T cells, and CD19+B cells in the peripheral blood by flow cytometry, as well as in the tumor microenvironment by immunohistochemistry of GC, and evaluated their correlations in different locations in order to determine their complicated interactions
Summary
Of new cases of gastric cancer (GC) and deaths are from developing countries, causing a social burden that cannot be ignored [1, 2]. Recent researches have shown that tumor-infiltrating lymphocytes can be used as predictive biomarkers for immunotherapy sensitivity in patients with liver cancer [14, 15]. These studies have indicated that inflammatory cells in the tumor microenvironment can classify patients into pathological stages and play a valuable predictive role in the response to cancer immunotherapy. In 2017, Choi et al [20] first reported that the NLR and PLR were associated with the density of immune cells in the tumor microenvironment, which leads to prognostic values of systemic inflammation in gastric cancer. We investigated the prognostic value of CD4+T cells, CD8+T cells, and CD19+B cells in the peripheral blood by flow cytometry, as well as in the tumor microenvironment by immunohistochemistry of GC, and evaluated their correlations in different locations in order to determine their complicated interactions
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
